The global healthcare contract development and manufacturing organization market size was valued at USD 204.52 billion in 2020 and is projected to register a substantial CAGR during the forecast period, 2021-2028. The market growth is attributed to rapid growth of the pharmaceutical industry, rise in the outsourcing by the pharmaceutical companies, and lowering the capital and operational expenses by contract development and manufacturing organization.
A company that provides services such as drug development through drug manufacturing and is being served to different other pharmaceutical companies is known as contract development and manufacturing organization. This is also widely called as a contract manufacturing organization. The outsourcing of the development and organization activities manufacturing is adopted majorly by small-sized pharmaceutical companies due to lack of internal capabilities.
The outbreak of COVID-19 pandemic had a challenging impact on the market as there are various unprecedented issues in front of the drug developers. The pandemic has brought drastic aspects of the pharmaceutical industry starting from drug development, drug manufacturing, their supplies, their trials, and then sending it to supply chain logistics. However, all the problems mentioned are short-term and are likely to overcome as the pandemic starts subsiding.
The report on the global healthcare contract development and manufacturing organization market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Healthcare Contract Development and Manufacturing Organization Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Services (Contract Development [Preclinical {Toxicology Testing, Bioanalysis & DMPK Studios, and Other Preclinical Services}, Clinical {Phase I, Phase II, Phase III, and Phase IV}, Laboratory Services {Analytical Services and Bioanalytical Services}] and Contract Manufacturing [API/BulknDrugs, Medical Devices {Class I, Class II, and Class III}, and Finished Dose Formulations]) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corp.; IQVIA Holdings Inc.; and Flex. |
On the basis of services, the global healthcare contract development and manufacturing organization market is bifurcated into contract development and contract manufacturing. The contract development segment is further divided into preclinical, clinical, and laboratory devices. The preclinical segment is sub-divided into toxicology testing, bioanalysis & DMPK studios, and other preclinical services. The clinical segment is further segmented into phase I, phase II, and phase III. The laboratory services are further bifurcated into analytical services and bioanalytical services.
The contract manufacturing segment is divided into API/bulk drugs, medical devices, and finished dose formulations. The medical devices segment is further divided into class I, class II, and class III. The contract manufacturing segment held a major share of the market in 2019 with a share of more than 70.2% and is anticipated to expand at a fast CAGR over the forecast period owing to complexity in manufacturing devices coupled with rise in the use of medical devices due to increase in incidence of chronic diseases.
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a key share of the market in 2019 and is expected to continue to do so over the forecast period. The regional market growth is attributed to increase in demand for pharmaceutical products as a result of which pharmaceutical companies start to outsource the manufacturing and development of drug to contract development and manufacturing organization. However, the market of Asia Pacific is expected to grow at a rapid pace in the coming years owing to low cost for manufacturing as compared to Europe and North America.
Segments Covered in the Report
The global contract development and manufacturing organization market has been segmented on the basis of
Services
Regions
Key Players
Key players competing in the global healthcare contract development and manufacturing organization market are Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corp.; IQVIA Holdings Inc.; and Flex. Many of these players have adopted business strategies such as launching new products, introducing new technology, merger, partnership, and production capacity expansion to increase their market position and expand their consumer base globally.
Some other reports from this category!